✦ LIBER ✦

182: Conventional Chemotherapy with Interferon Versus Conventional Chemotherapy followed by High Dose Chemotherapy and Autologous Stem Cell Transplantation in Untreated Patients with Advanced Follicular Lymphoma. A Meta-Analysis of Randomized Clinical Trials

✍ Scribed by E. Ayala; A. Kumar

Book ID: 116280010
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 52 KB
Volume: 14
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.12.191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The hyper-CVAD–rituximab chemotherapy pr

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

✍ D. S. Ritchie; J. F. Seymour; A. P. Grigg; A. W. Roberts; R. Hoyt; S. Thompson; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 113 KB

Conventional Chemotherapy Followed By Co

Conventional Chemotherapy Followed By Consolidation With Autologous Hematopoietic Transplantation vs Chemotherapy Alone In HIV+ Patients With Large B Cell Lymphoma (LBCL) In First Complete Remission (CR). A Retrospective Analysis On Behalf Of The EBMT Lymphoma Working Party And The GESIDA/PETHEMA Registry Of HIV+ Patients With Non-Hodgkin's Lymphoma (NHL)

✍ P. Balsalobre; J. Berenguer; P. Miralles; D. Serrano; J.M. Ribera; C. Canals; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A randomized trial of chemotherapy with

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB

Prognostic Factors and Clinical Outcomes

Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome

✍ Deok-Hwan Yang; Won Seog Kim; Seok Jin Kim; Sung Hwa Bae; Sung Hyun Kim; In Ho K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views